ALPP and neoplasm: Two isoforms of the prodrug are present (IQ2-P(I) and IQ2-P), and their structural alterations were studied via molecular modeling and docking methods, in order to elucidate the interaction among the prodrugs and the enzyme human placental alkaline phosphatase (PLAP), a membrane-bound hydrolytic enzyme of the tumor cell.